Valuation : EBOS Group Limited

Market Cap 3.36B 2.41B 2.07B 1.96B 1.78B 3.33B 230B 23.3B 8.97B 117B 9.05B 8.86B 371B P/E 2027 *
14.3x
P/E 2028 * 12.7x
Enterprise Value 4.38B 3.14B 2.7B 2.55B 2.32B 4.34B 300B 30.32B 11.67B 152B 11.78B 11.53B 483B EV / Sales 2027 *
0.31x
EV / Sales 2028 * 0.3x
Free-Float
89.8%
Yield 2027 *
5.84%
Yield 2028 * 6.33%
1 day-0.38%
6 months-31.02%
Current year-25.78%
1 week 26
Extreme 26
26.61
1 month 26
Extreme 26
26.61
Current year 24.21
Extreme 24.21
46.64
1 year 24.21
Extreme 24.21
46.64
3 years 24.21
Extreme 24.21
47.23
5 years 24.21
Extreme 24.21
47.23
10 years 24.21
Extreme 24.21
47.23
Manager TitleAgeSince
Chief Executive Officer 51 01/07/2025
Director of Finance/CFO - 30/09/2024
Chief Tech/Sci/R&D Officer - 05/08/2024
Director TitleAgeSince
Chairman 66 -
Director/Board Member - 01/07/2019
Director/Board Member 60 01/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
-0.38%0.00% - - 2.41B
-1.21%-4.40%+24.72%+109.34% 103B
-1.66%-5.06%+58.09%+165.85% 54.89B
-0.38%-2.59%-12.33%+250.67% 21.78B
-1.03%-0.79%-10.14%-7.64% 8.09B
-1.33%-3.06%-37.05%-28.50% 6.96B
-0.11%-0.23%+2.56%+30.55% 6.79B
-0.90%-2.10%-19.20%-29.86% 6.17B
+1.27%+0.97%-3.63%+20.78% 5.08B
-10.00%+1.12%+354.83%+495.04% 5.12B
Average -1.57%+0.05%+39.76%+111.80% 24.17B
Weighted average by Cap. -1.33%-2.67%+31.34%+129.60%

Financials

2027 *2028 *
Net sales 14.03B 10.06B 8.65B 8.17B 7.44B 13.91B 962B 97.25B 37.43B 488B 37.79B 36.96B 1,550B 14.66B 10.51B 9.04B 8.53B 7.77B 14.53B 1,005B 102B 39.09B 510B 39.47B 38.61B 1,619B
Net income 229M 164M 141M 133M 122M 227M 15.73B 1.59B 612M 7.98B 618M 604M 25.34B 261M 187M 161M 152M 138M 259M 17.9B 1.81B 696M 9.08B 703M 688M 28.84B
Net Debt 1.01B 727M 625M 590M 537M 1B 69.5B 7.02B 2.7B 35.25B 2.73B 2.67B 112B 975M 699M 601M 567M 517M 966M 66.83B 6.75B 2.6B 33.9B 2.62B 2.57B 108B
Logo EBOS Group Limited
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also the owner, product marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, through its own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics, Healthcare Logistics Clinical Trials and Clinect.
Employees
5,364
Date Price Change Volume
08/09/26 $26.00 -0.38% 1,455
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
16.24AUD
Average target price
23.56AUD
Spread / Average Target
+45.03%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!